DK0679718T3 - Fremgangsmåde til fremstilling af alfa-interferon - Google Patents
Fremgangsmåde til fremstilling af alfa-interferonInfo
- Publication number
- DK0679718T3 DK0679718T3 DK95104596T DK95104596T DK0679718T3 DK 0679718 T3 DK0679718 T3 DK 0679718T3 DK 95104596 T DK95104596 T DK 95104596T DK 95104596 T DK95104596 T DK 95104596T DK 0679718 T3 DK0679718 T3 DK 0679718T3
- Authority
- DK
- Denmark
- Prior art keywords
- alpha
- production
- alpha interferon
- free
- ifn
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B21—MECHANICAL METAL-WORKING WITHOUT ESSENTIALLY REMOVING MATERIAL; PUNCHING METAL
- B21B—ROLLING OF METAL
- B21B13/00—Metal-rolling stands, i.e. an assembly composed of a stand frame, rolls, and accessories
- B21B13/06—Metal-rolling stands, i.e. an assembly composed of a stand frame, rolls, and accessories with axes of rolls arranged vertically, e.g. edgers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP94105532 | 1994-04-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0679718T3 true DK0679718T3 (da) | 2001-10-22 |
Family
ID=8215847
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95104596T DK0679718T3 (da) | 1994-04-09 | 1995-03-29 | Fremgangsmåde til fremstilling af alfa-interferon |
Country Status (7)
Country | Link |
---|---|
US (1) | US6005075A (da) |
EP (2) | EP0679718B1 (da) |
JP (1) | JP2859162B2 (da) |
AT (1) | ATE205256T1 (da) |
DE (1) | DE69522492T2 (da) |
DK (1) | DK0679718T3 (da) |
ES (1) | ES2161793T3 (da) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW491855B (en) * | 1996-08-07 | 2002-06-21 | Csl Ltd | Purification of immunoglobulins |
SK287372B6 (sk) * | 1998-11-12 | 2010-08-09 | Schering Corporation | Spôsob zvýšenia výťažku prostriedku obsahujúceho interferón-alfa |
EP1140144A4 (en) * | 1998-12-31 | 2002-10-30 | Viragen Inc | METHODS AND COMPOSITION OF EXTREMELY PURIFIED NATURAL MIXTURES OF TYPE I INTERFERONS DERIVED FROM LEUCOCYTES |
EP1268514B1 (en) * | 2000-03-27 | 2006-06-07 | Genetics Institute, LLC | Methods for purifying highly anionic proteins |
DK1404428T3 (da) * | 2001-06-05 | 2006-10-30 | Genetics Inst Llc | Fremgangsmåder til oprensning af stærkt anioniske proteiner |
ITBO20010426A1 (it) | 2001-07-06 | 2003-01-06 | Alfa Wassermann Spa | Processo per la purificazione di proteine farmacologicamente attive mediante cromatografia in scambio cationico |
ITMI20012345A1 (it) * | 2001-11-08 | 2003-05-08 | Internat Ct For Genetic En Gin | Procedimento per la produzione di interferone alfa di grado terapeutico |
AU2002304965A1 (en) | 2002-05-24 | 2003-12-12 | Zensun (Shanghai) Sci-Tech.Ltd | Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy |
US20060018875A1 (en) * | 2004-06-14 | 2006-01-26 | Blatt Lawrence M | Interferon compositions and methods of use thereof |
JP5944101B2 (ja) * | 2008-01-18 | 2016-07-05 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 非グリコシル化タンパク質の精製 |
SG172386A1 (en) | 2008-12-23 | 2011-08-29 | Schering Corp | Purification of recombinantly produced interferon |
DE102010046817A1 (de) * | 2010-09-28 | 2012-03-29 | Sartorius Stedim Biotech Gmbh | Verfahren zur Abtrennung von Viren aus einem Kontaminanten enthaltenden flüssigen Medium |
CN114671944A (zh) * | 2022-04-29 | 2022-06-28 | 江苏尤里卡生物科技有限公司 | 一种人绒毛膜促性腺激素纯化方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH651308A5 (de) * | 1980-07-01 | 1985-09-13 | Hoffmann La Roche | Interferone und deren herstellung. |
US4485038A (en) * | 1982-10-19 | 1984-11-27 | Health Research (Roswell Park Division) | Method for the production and purification of human leukocyte interferon |
US4620948A (en) * | 1982-12-22 | 1986-11-04 | Genentech, Inc. | Purification and activity assurance of precipitated heterologous proteins |
CA1231306A (en) * | 1983-03-03 | 1988-01-12 | Erich Hochuli | Purification of interferon |
AU598455B2 (en) * | 1984-12-27 | 1990-06-28 | Suntory Limited | Method for purifying an interferon |
DE3515336C2 (de) * | 1985-04-27 | 1994-01-20 | Boehringer Ingelheim Int | Verfahren zur Herstellung und Reinigung von â-Interferon |
JPS6411640A (en) * | 1987-07-02 | 1989-01-17 | Engelhard Nippon | Precious metal adsorbent |
MX9102512A (es) * | 1990-12-14 | 1992-06-01 | Schering Corp | Administracion oral de interferon alfa en el tratamiento de enfermedades del pulmon. |
AU648214B2 (en) * | 1991-12-31 | 1994-04-14 | Lucky Limited | Recombinant gene coding for human alpha interferon and expression vector thereof, etc. |
-
1995
- 1995-03-29 ES ES95104596T patent/ES2161793T3/es not_active Expired - Lifetime
- 1995-03-29 DK DK95104596T patent/DK0679718T3/da active
- 1995-03-29 AT AT95104596T patent/ATE205256T1/de active
- 1995-03-29 EP EP95104596A patent/EP0679718B1/en not_active Expired - Lifetime
- 1995-03-29 EP EP01103144A patent/EP1104809A1/en not_active Withdrawn
- 1995-03-29 DE DE69522492T patent/DE69522492T2/de not_active Expired - Lifetime
- 1995-04-07 JP JP7082602A patent/JP2859162B2/ja not_active Expired - Lifetime
-
1997
- 1997-07-23 US US08/899,037 patent/US6005075A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0679718A2 (en) | 1995-11-02 |
EP0679718B1 (en) | 2001-09-05 |
ES2161793T3 (es) | 2001-12-16 |
EP0679718A3 (en) | 1996-08-21 |
ATE205256T1 (de) | 2001-09-15 |
US6005075A (en) | 1999-12-21 |
DE69522492T2 (de) | 2002-05-23 |
EP1104809A1 (en) | 2001-06-06 |
JP2859162B2 (ja) | 1999-02-17 |
DE69522492D1 (de) | 2001-10-11 |
JPH07322887A (ja) | 1995-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0679718T3 (da) | Fremgangsmåde til fremstilling af alfa-interferon | |
DE69003175T2 (de) | Verfahren und Vorrichtung zur Plasmaaussenabscheidung von hydroxylionenfreier Silika. | |
DE69031748T2 (de) | Plasmabehandlung mit Metallmasken-Integration | |
DE59101397D1 (de) | O-glycosyliertes ifn-alpha. | |
DE69226253T2 (de) | Plasmaätzverfahren und Reaktor zur Plasmabearbeitung | |
HUP9802324A2 (hu) | Ribavirin és alfa-interferon felhasználása hepatitis C kezelésére | |
DE600440T1 (de) | Verfahren und Vorrichtung zur Reinigung von Abgasen. | |
DE69110359D1 (de) | Zusammensetzung zur Reinigung von elektronischen und Präzisionsteilen und Reinigungsverfahren. | |
DE59103741D1 (de) | Verfahren zur reduktiven Dehydrohalogenierung von Halogenkohlenwasserstoffen und Halogenethern. | |
ES2035668T3 (es) | Uso de moleculas de adherencia intercelular y sus ligandos de union en el tratamiento del asma. | |
DE59002994D1 (de) | Vorrichtung zur selektiven Elimination von Plasmabestandteilen aus Blut. | |
ITRM910144A1 (it) | Fibra di ceramica, metallo o carbonio rivestita e procedimento diproduzione | |
DE59102062D1 (de) | Verfahren zur biologischen Reinigung von Abluftströmen. | |
DE59106539D1 (de) | Verfahren zur Oberflächenbehandlung von Bauteilen. | |
DE69011806D1 (de) | Gesinterter Glas-Keramikkörper und Verfahren. | |
DE58905302D1 (de) | Rollenherdofen zur waermebehandlung, insbesondere von kleinteilen aus metall und keramik. | |
DE69131657D1 (de) | Verfahren zur industriellen Herstellung von 4-Chloro-3-sulfamoyl-N-(2,3-dihydro-2-methyl-1H-indol-1-yl)-Benzamid | |
DE69014057T2 (de) | Verfahren zur Schmelzreduktion von Metallen und Schmelzreduktionsofen. | |
DE59500343D1 (de) | Verfahren und Vorrichtung zur Aufbereitung von Lampen | |
DE69105823T2 (de) | Verfahren zur Behandlung von Metallmatrixverbundwerkstoffen. | |
ATE94588T1 (de) | Verfahren zur herstellung und reinigung von alpha-interferon. | |
DE69014501D1 (de) | Verfahren zur Behandlung von Titanlegierung und damit hergestelltes Stück. | |
DE69112474D1 (de) | Verfahren zur oberflächlichen Entionisierung von Glasbändern, Vorrichtung dafür und erhaltene entionisierte Produkte. | |
DE69011567D1 (de) | Verfahren zur Herstellung von elektronischen und optischen Komponenten. | |
DE69635131D1 (de) | Verwendung von beta-interferon zur behandlung der restenose |